Mesalamine Tablet, Delayed Release
Product Images NDC 65162-360

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Mesalamine (NDC 65162-360). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Amneal Pharmaceuticals Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula (Mesalamine Delayed Release Tablets Usp 800 mg 1)

Chemical structure of Mesalamine showing a benzene ring with amino, carboxyl, and hydroxyl functional groups. Molecular weight is 153.1 and molecular formula is C7H7NO3, as indicated in the diagram.*

FDA Label Image

Label (Mesalamine Delayed Release Tablets Usp 800 mg 2)

Label for Mesalamine Delayed-Release Tablets, USP 800 mg by Amneal Pharmaceuticals LLC. The label shows the product name, strength, and dosage form, specifying 180 tablets per container. It includes usage instructions, storage temperature ranges, and a representative image of an oblong brown tablet marked 'AN360'. The label also contains a barcode and advises swallowing tablets whole without cutting or chewing.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.